Panacea Index Logo

Command Palette

Search for a command to run...

Nutraceuticals in the Mediterranean Diet: Potential Avenues for Breast Cancer Treatment.

Nutrients
January 1, 1970
Giuseppina Augimeri et al. (9 authors)
Journal ArticleReviewMolecular Study
Study Details

Study Goal

The researchers aimed to summarize the anticancer mechanisms of Epigallocatechin Gallate (EGCG) and other bioactive compounds in the context of breast cancer.

Results Summary

The study found that EGCG exhibits anticancer properties by modulating cell cycle arrest, apoptosis, inflammation, and angiogenesis, supported by in vitro and in vivo evidence. It highlights EGCG's potential as a future therapeutic candidate for breast cancer.

Population

Not specified (review of in vitro and in vivo studies).

Effective Dosage

Not specified

Duration

Not specified

Interactions

None mentioned

Extracted Claims (8)
InterventionDirectionEndpointPopulationDosageImpactClaim #
Mediterranean-style diet
decrease
chronic illnesses, such as cardiovascular and neurodegenerative diseases and cancer including breast carcinoma
population living in countries bordering the Mediterranean Sea
-
provides several dietary compounds that have been reported to exert beneficial biological effects
#1
natural polyphenols, retinoids, and polyunsaturated fatty acids (PUFAs)
increase
antioxidant, anti-inflammatory, immunomodulatory and antitumoral properties
-
-
have been reported to possess
#2
natural polyphenols, retinoids, and polyunsaturated fatty acids (PUFAs)
decrease
breast cancer
-
-
identified as protective factors for
#3
some polyphenols, like resveratrol and epigallocatechin 3-gallate, retinoids and omega-3 PUFAs
increase
cell cycle growth arrest
-
-
anticancer action
#4
some polyphenols, like resveratrol and epigallocatechin 3-gallate, retinoids and omega-3 PUFAs
increase
apoptosis
-
-
anticancer action
#5
some polyphenols, like resveratrol and epigallocatechin 3-gallate, retinoids and omega-3 PUFAs
decrease
inflammation
-
-
anticancer action
#6
some polyphenols, like resveratrol and epigallocatechin 3-gallate, retinoids and omega-3 PUFAs
decrease
angiogenesis
-
-
anticancer action
#7
these natural compounds
decrease
breast cancer disease
-
-
could be the prospective candidates for the future anticancer therapeutics
#8
Abstract

The traditional Mediterranean Diet constitutes a food model that refers to the dietary patterns of the population living in countries bordering the Mediterranean Sea in the early 1960s. A huge volume of literature data suggests that the Mediterranean-style diet provides several dietary compounds that have been reported to exert beneficial biological effects against a wide spectrum of chronic illnesses, such as cardiovascular and neurodegenerative diseases and cancer including breast carcinoma. Among bioactive nutrients identified as protective factors for breast cancer, natural polyphenols, retinoids, and polyunsaturated fatty acids (PUFAs) have been reported to possess antioxidant, anti-inflammatory, immunomodulatory and antitumoral properties. The multiple anticancer mechanisms involved include the modulation of molecular events and signaling pathways associated with cell survival, proliferation, differentiation, migration, angiogenesis, antioxidant enzymes and immune responses. This review summarizes the anticancer action of some polyphenols, like resveratrol and epigallocatechin 3-gallate, retinoids and omega-3 PUFAs by highlighting the important hallmarks of cancer in terms of (i) cell cycle growth arrest, (ii) apoptosis, (iii) inflammation and (iv) angiogenesis. The data collected from in vitro and in vivo studies strongly indicate that these natural compounds could be the prospective candidates for the future anticancer therapeutics in breast cancer disease.

Medical Subject Headings (MeSH)
AnimalsAntineoplastic AgentsApoptosisBreast NeoplasmsCatechinCell Cycle CheckpointsDiet, MediterraneanDietary SupplementsFatty Acids, Omega-3FemaleHumansInflammationPolyphenolsResveratrolRetinoids
Study Links
Quality Scores
SafetyNot Assessed
Efficacy85/10
Quality78/10
Citation Metrics
Total Citations36
Citations/Year9.0
Relative Citation Ratio3.48
NIH Percentile87.8%
Research Impact Scores
APT Score0.75
Weight Score0.89
Normalized Score0.70
Related Supplements